| Project/Area Number |
22K01071
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Review Section |
Basic Section 04030:Cultural anthropology and folklore-related
|
|---|
| Research Institution | Hokkaido University |
|---|
Principal Investigator |
COOK EMMA 北海道大学, メディア・コミュニケーション研究院, 教授 (90745788)
|
|---|
| Project Period (FY) |
2022-04-01 – 2027-03-31
|
| Project Status |
Granted (Fiscal Year 2023)
|
| Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2025: ¥260,000 (Direct Cost: ¥200,000、Indirect Cost: ¥60,000)
Fiscal Year 2024: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2023: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2022: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
|
|---|
| Keywords | food allergy treatments / Food Allergy / food allergies / chronic illness / medical treatment / risk |
|---|
| Outline of Research at the Start |
This project seeks to answer: what are the social, cultural and medical factors that lead to different understandings and availability of food allergy treatments in Japan and the UK? To answer this I will explore the following questions: 1. What factors shape the different availability of OIT as a potential treatment in Japan and the UK? 2. How do cultural ideas of food, health and illness shape medical and parent/patient narratives of food allergy experiences and understandings of OIT? and 3. How do these ideas shape institutional arrangements (e.g. availability of treatments)?
|
| Outline of Annual Research Achievements |
In 2023 I focused on gathering data on the current state of food allergy treatments options and advancements in the field by attending the European Academy of Allergy and Immunology (EAACI) conference online and the 第 72 回日本アレルギー学会学術大会 in person in Tokyo. I began coding and analysing the transcripts of 28 initial interviews I conducted in Japan in June and July 2022 and have begun to ascertain how treatment options shape understandings and experiences of food allergies. Continuing on from 2022, I participated in the COMFA initiative (https://comfa.eu) which brought together various stakeholders (including researchers, clinicians, patients and representatives from patient organisations) to develop a core outcome set for future food allergy clinical trials, which was published in 2024 in the journal Allergy. I also published an article in the journal Clinical & Experimental Allergy on anthropological and sociological approaches to food allergy that was aimed at a clinical audience.
|
| Current Status of Research Progress |
Current Status of Research Progress
3: Progress in research has been slightly delayed.
Reason
I had initially planned to organise in-hospital/in-clinic fieldwork to observe food allergy treatments and therapies in situ. Due to a variety of factors, however, I did not attempt to organise this in Japan or the UK but decided to first focus on analysing the initial data I gathered in 2022 and to attend relevant scientific conferences on allergy in Europe and Japan to ascertain the current status of food allergy treatments.
|
| Strategy for Future Research Activity |
It is my intention to try and secure access to observing food allergy treatments in hospitals/clinics in Japan in 2024. In addition I plan to conduct more interviews on food allergy treatment experiences with patients and their families in Japan in August. I will also attend the European Academy of Allergy and Immunology (EAACI) conference online in June, the 第 73 回日本アレルギー学会学術大会 in person in Kyoto in October, and the FAAM-Eurobat (Food Allergy Anaphylaxis Meeting) in Athens in November.
|
